Senior Director, Market Access Brisbane, California

Senior Director, Market Access

Freenome is a high-growth biotech company developing tests to detect cancer using a standard blood draw. To do this, Freenome uses a multiomics platform that combines tumor and non-tumor signals with machine learning to find cancer in its earliest, most-treatable stages. Cancer is relentless. This is why Freenome is building the clinical, economic, and operational evidence to drive cancer screening and save lives. Our first screening test is for colorectal cancer (CRC) and advanced adenomas, and it's just the beginning. Founded in 2014, Freenome has ~400 employees and continues to grow to match the scope of our ambitions to provide access to better screening and earlier cancer detection. At Freenome, we aim to impact patients by empowering everyone to prevent, detect, and treat their disease. This, together with our high-performing culture of respect and cross-collaboration, is what motivates us to make every day count.

Become a Freenomer

A "Freenomer" is a determined, mission-driven, results-oriented employee fueled by the opportunity to change the landscape of cancer and make a positive impact on patients' lives. Freenomers bring their diverse experience, expertise, and personal perspective to solve problems and push to achieve what's possible, one breakthrough at a time.

About this opportunity

Freenome is looking for a Senior Director, Market Access to bolster our Commercial team. We're looking for a candidate with hands-on Market Access & Reimbursement experience for an in vitro diagnostic (IVD) during the critical launch and early commercialization stages. In this role, you will be instrumental in crafting and executing market access strategies that will be key to the successful commercialization of our products. Your commitment to patient care and access will significantly contribute to our growth and our mission to outpace cancer with early detection. Reporting directly to the Chief Commercial Officer, this role will serve as a vital part of the Commercial leadership team. There is a preference for this to be Hybrid, based in our Brisbane, California headquarters; however, we will consider remote for an exceptional candidate.

What you'll do

Market Access & Pricing

• Spearhead the development and execution of market access strategies to enhance patient access, secure reimbursement, and encourage product adoption
• Lead coding, coverage, and pricing initiatives to ensure reimbursement for our CRC screening test upon FDA approval and future product pipeline
• Craft access, reimbursement, and contracting strategies for various payer segments and geographies, aligning with our go-to-market roadmap
• Perform pricing analysis and modeling to establish optimal pricing and contracting that maximizes patient access and revenue
• Identify and build out the appropriate team to support our market access goals
• Collaborate with commercial, finance, and medical teams to develop value propositions, payer messaging, pricing strategies, and evidence generation plans that support our market access goals
• Offer strategic leadership on policy issues, access-related market dynamics, and reimbursement

External Engagement

Cross-Functional Launch Execution

Other

Must haves

Nice to haves

Benefits and additional information

The US target range of our base salary rate for new hires is $236,300 - $360,500. You will also be eligible to receive pre-IPO equity, cash bonuses, and a full range of medical, financial, and other benefits depending on the position offered. Please note that individual total compensation for this position will be determined at the Company's sole discretion and may vary based on several factors, including but not limited to, location, skill level, years and depth of relevant experience, and education.

Freenome is proud to be an equal-opportunity employer, and we value diversity. Freenome does not discriminate on the basis of race, color, religion, marital status, age, national origin, ancestry, physical or mental disability, medical condition, pregnancy, genetic information, gender, sexual orientation, gender identity or expression, veteran status, or any other status protected under federal, state, or local law.